Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chron Respir Dis ; 16: 1479972318767719, 2019.
Article in English | MEDLINE | ID: mdl-29621888

ABSTRACT

Asthma is the most common chronic medical condition affecting pregnancy. Optimizing asthma management in pregnancy is paramount for the well-being of both the mother and the baby. The primary objectives of this study were to assess patient's knowledge about asthma, the level of asthma care, and fetal and maternal outcomes among pregnant asthmatic women in this wealthy country with tremendous improvement in maternal and fetal health care. The secondary objective was to identify barriers to asthma control. This was a cross-sectional, face-to-face, prospective study of 80 pregnant women with physician-diagnosed asthma. About 56% of patients reported worsening of their asthma control during pregnancy, of which 52.3% felt this worsening in the third trimester. About 65% of patients had uncontrolled asthma during their pregnancy, and inhaler technique was incorrect in 64.4%. Only 38% of patients knew the difference between controller and reliever asthma medications, 12.7% of patients had received written asthma action plan, 17% had a spirometry done in the previous 5 years, and 3.8% had peak expiratory flow meter at home. The main reasons for uncontrolled asthma were lack of knowledge about right asthma medications in 30% and fear of side effects of inhaled corticosteroids in 19% of patients. No financial reason was reported. Significant associations between total number of pregnancies, poor perception of asthma medications, asthma exacerbation during delivery and poor asthma control were observed. Preeclampsia and congenital anomalies occurred at higher rates than previously reported among general population in this country. The tremendous improvements in maternal health care and socioeconomic status do not seem to be a barrier to the globally recognized poor asthma care in pregnancy. Important strategies are much needed.


Subject(s)
Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Developed Countries , Health Knowledge, Attitudes, Practice , Pregnancy Complications/epidemiology , Adrenal Cortex Hormones/adverse effects , Adult , Anti-Asthmatic Agents/adverse effects , Asthma/physiopathology , Asthma/psychology , Cross-Sectional Studies , Disease Progression , Female , Humans , Incidence , Length of Stay/statistics & numerical data , Metered Dose Inhalers , Patient Care Planning/statistics & numerical data , Pregnancy , Pregnancy Trimesters/physiology , Prospective Studies , Qatar/epidemiology , Spirometry/statistics & numerical data
2.
Can Respir J ; 2018: 7649629, 2018.
Article in English | MEDLINE | ID: mdl-30662579

ABSTRACT

Data on inhaler technique and its effects on maternal and fetal outcomes during pregnancy are seldom reported. The primary objective of this study was to evaluate inhaler technique and identify errors in inhaler use among pregnant women with asthma. Secondary objectives were to identify factors associated with poor inhaler technique and study the association between inhaler technique and maternal and fetal outcomes. This was a cross-sectional, face-to-face, prospective study of 80 pregnant women with physician-diagnosed asthma. Seventy-three and 41 asthmatic pregnant women reported using pressurized metered dose inhalers (pMDIs) and dry powder inhalers (DPIs), respectively. Overall, wrong inhaler technique was observed in 47 (64.4%) subjects. Among pMDI users, correct inhaler use was observed in only 26/73 (35.6%) of the patients, with lack of coordination between inhalation and generation of the aerosol and failure to breathe out gently before using the inhaler, being the most common errors. Among DPI users, 21 (51.2%) demonstrated correct inhaler use, with failure to perform a breath-hold for 10 seconds after inhaling the powder and to exhale gently before using the inhaler being the most common errors. Significant associations between inhaler technique and patient's understanding of asthma medications and the kind of follow-up clinic (respiratory versus nonrespiratory clinic) were found. No significant associations between inhaler technique and various maternal and fetal outcomes or asthma control were found. In conclusion, improper inhalation technique is significantly prevalent in pregnant asthmatic women, particularly among those being followed in nonspecialized respiratory clinics. The lack of significant association between the inhaler technique and asthma control (and hence maternal and fetal outcomes) may simply reflect the high prevalence of uncontrolled asthma and significant contribution of other barriers to poor asthma control in the current patient's cohort. Multidisciplinary management of asthma during pregnancy with particular emphasis on patient's education is imperative.


Subject(s)
Anti-Asthmatic Agents/administration & dosage , Asthma/drug therapy , Patient Medication Knowledge , Pregnancy Complications/drug therapy , Administration, Inhalation , Adult , Albuterol/administration & dosage , Budesonide/administration & dosage , Budesonide, Formoterol Fumarate Drug Combination/administration & dosage , Cesarean Section/statistics & numerical data , Congenital Abnormalities/epidemiology , Cross-Sectional Studies , Disease Progression , Dry Powder Inhalers , Female , Fluticasone-Salmeterol Drug Combination/administration & dosage , Humans , Infant, Low Birth Weight , Infant, Newborn , Metered Dose Inhalers , Pregnancy , Prospective Studies , Qatar/epidemiology , Respiratory Distress Syndrome, Newborn/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...